Westmount Partners’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.14M | Sell |
85,999
-1,890
| -2% | -$47K | 0.59% | 39 |
|
2025
Q1 | $2.73M | Sell |
87,889
-2,445
| -3% | -$75.8K | 0.83% | 25 |
|
2024
Q4 | $2.85M | Sell |
90,334
-1,799
| -2% | -$56.7K | 0.87% | 25 |
|
2024
Q3 | $5.34M | Sell |
92,133
-1,645
| -2% | -$95.3K | 1.61% | 14 |
|
2024
Q2 | $3.73M | Sell |
93,778
-1,917
| -2% | -$76.2K | 1.23% | 15 |
|
2024
Q1 | $4.02M | Sell |
95,695
-1,830
| -2% | -$76.8K | 1.45% | 14 |
|
2023
Q4 | $3.74M | Sell |
97,525
-2,135
| -2% | -$81.8K | 1.53% | 12 |
|
2023
Q3 | $3.07M | Sell |
99,660
-1,920
| -2% | -$59.2K | 1.35% | 13 |
|
2023
Q2 | $3.21M | Sell |
101,580
-1,735
| -2% | -$54.8K | 1.4% | 14 |
|
2023
Q1 | $3.77M | Sell |
103,315
-6,450
| -6% | -$235K | 1.74% | 11 |
|
2022
Q4 | $3.25M | Buy |
+109,765
| New | +$3.25M | 1.69% | 11 |
|